Are Companies Restricted from Providing Ongoing Clinical Trial Info?

Will aderans send out an update on what they are doing or there progress so far with their phase two study? Do they have to keep their trials confidential or are there rules that restrict them from giving out information before the trials are complete?

Update: See this post

I think the FDA frowns upon companies that release information prematurely, which may impact the ability of those companies to get the FDA clearance they need from clinical trials. While I don’t know about legal restrictions, I doubt any company would want to publish such information early. These companies have a difficult task of balancing what their investors want to know (to keep those that supply the money happy), and the need for good science. Revealing too much before the clinical trials are concluded doesn’t seem to be in their best interest, as reading an incomplete study is essentially like watching a movie with the ending cut off. Lots of things could change by the end.

I don’t have any info on Aderans specifically, but here’s their page about Phase 2 study info.